- Home
- PTCT vs SNEX Comparison
PTCT vs SNEX Comparison
Compare PTCT & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- SNEX
- Stock Information
- Founded
- PTCT 1998
- SNEX 1924
- Country
- PTCT United States
- SNEX United States
- Employees
- PTCT N/A
- SNEX N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- SNEX Investment Bankers/Brokers/Service
- Sector
- PTCT Health Care
- SNEX Finance
- Exchange
- PTCT Nasdaq
- SNEX Nasdaq
- Market Cap
- PTCT 4.1B
- SNEX 4.4B
- IPO Year
- PTCT 2013
- SNEX 1994
- Fundamental
- Price
- PTCT $50.57
- SNEX $98.84
- Analyst Decision
- PTCT Buy
- SNEX Buy
- Analyst Count
- PTCT 14
- SNEX 1
- Target Price
- PTCT $67.14
- SNEX N/A
- AVG Volume (30 Days)
- PTCT 1.5M
- SNEX 685.5K
- Earning Date
- PTCT 08-07-2025
- SNEX 08-05-2025
- Dividend Yield
- PTCT N/A
- SNEX N/A
- EPS Growth
- PTCT N/A
- SNEX 21.85
- EPS
- PTCT 7.72
- SNEX 5.86
- Revenue
- PTCT $1,764,929,000.00
- SNEX $129,411,800,000.00
- Revenue This Year
- PTCT $119.89
- SNEX N/A
- Revenue Next Year
- PTCT N/A
- SNEX $13.82
- P/E Ratio
- PTCT $6.55
- SNEX $16.86
- Revenue Growth
- PTCT 96.00
- SNEX 53.56
- 52 Week Low
- PTCT $30.41
- SNEX $50.31
- 52 Week High
- PTCT $58.38
- SNEX $100.40
- Technical
- Relative Strength Index (RSI)
- PTCT 56.09
- SNEX 61.39
- Support Level
- PTCT $48.09
- SNEX $93.82
- Resistance Level
- PTCT $54.24
- SNEX $97.35
- Average True Range (ATR)
- PTCT 2.37
- SNEX 4.22
- MACD
- PTCT 0.19
- SNEX 0.60
- Stochastic Oscillator
- PTCT 66.83
- SNEX 95.62
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.